Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 159 results found. Search for [ Rajeev Dubey. Business Today Editor ]

Results 20 to 40 of 159
Rajeev Dubey
New Delhi, January 11, 2021
As vaccines get emergency use authorisation, the question remains as to when full vaccine approval might be granted. WHO's Chief Scientist Dr Soumya Swaminathan spoke to Rajeev Dubey, Editor, Business Today about the process to get full vaccine approval. She also explained how COVID-19 vaccine development can have learnings for future vaccines. Watch the video for more.DCGI needs communication strategy on COVID-19 approvals: WHO's Swaminathan


Rajeev Dubey
New Delhi, January 6, 2021
Dr Krishna Ella, Chairman of Bharat Biotech, said that unlike the clinical trials of AstraZeneca vaccine (which has been licensed to Serum Institute of India), Bharat Biotech did not try to suppress the side effects of vaccine by giving paracetamol to the volunteers. He also said that for his company safety came first. Watch him in conversation with Rajeev Dubey, Editor, Business Today.Also Read: China denies entry to WHO team investigating COVID-19 origins


Rajeev Dubey
New Delhi, January 6, 2021
The vaccine produced by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology, Pune, has courted many controversies since it began its first human trials. In this video, Bharat Biotech chief Dr Krishna Ella talks to Business Today Editor, Rajeev Dubey, about vaccine efficacy and why people get suspicious about Indian companies.


Rajeev Dubey
New Delhi, January 6, 2021
The New Year raises new hopes, new expectations, new aspirations - even new anxieties. Finance Minister Nirmala Sitharaman has raised hopes by inviting ideas to spur growth with a promise to deliver \"a Budget like never before\"


Team BT
New Delhi, January 6, 2021
How the FM can make it a 'never before' Budget. Top experts weigh in


Rajeev Dubey
New Delhi, January 6, 2021
Many lessons have been learnt by the healthcare sector during the duration of the pandemic. Speaking to Rajeev Dubey, Editor, Business Today, Dr Krishna Ella, chairman of Bharat Biotech elaborated on the future of healthcare in the country and the lessons that have been learnt. Dr Ella looks forward to a national task force on the pandemic to plug the gaps in healthcare. Watch the video for more.


Rajeev Dubey
New Delhi, January 5, 2021
Dr Krishna Ella, Bharat Biotech chairman spoke to Business Today editor Rajeev Dubey about the efficacy of Covaxin and what makes it safe for use. He said his vaccine was stable and they had data for four months to substantiate the claim. Watch the video for more.


Rajeev Dubey
New Delhi, January 5, 2021
As urbanisation and deforestation takes place, and global travel increases, viruses get the right environment to mutate and thereby grow. In such a situation how can one prepare for the future ? Watch as Dr Krishna Ella, chairman, Bharat Biotech, shares his views with Business Today editor, Rajeev Dubey.


Rajeev Dubey
New Delhi, January 5, 2021
As urbanisation and deforestation takes place, and global travel increases, viruses get the right environment to mutate and thereby grow. In such a situation how can one prepare for the future ? Watch as Dr Krishna Ella, chairman, Bharat Biotech, shares his views with Business Today editor, Rajeev Dubey.


Rajeev Dubey
New Delhi, December 24, 2020
As one of history's most disruptive and dreaded year draws to a close, we look forward to 2021 with renewed hope and excitement. Wishing you all a very Happy New Year, with gratitude


Rajeev Dubey
New Delhi, December 9, 2020
Mukesh Ambani's Reliance Retail, Jeff Bezos's Amazon Inc. and the Walton family's Walmart-Flipkart combo are pitching themselves for the long haul in Indian retail


Rajeev Dubey
New Delhi, December 4, 2020
BSE Sensex breached the 45,000 mark for the first time today, recording an unprecedented high, as RBI kept its repo rate unchanged. The central bank revised its forecast of economic growth for the current fiscal year 2021 to - 7.5%. Watch the video as Rajeev Dubey, Editor, Business Today, explains the reasons behind the jump in  sensex numbers.


Rajeev Dubey
New Delhi, December 1, 2020
GDP growth in the second quarter of FY 21 has turned out to be better than anticipated. The momentum appears to be back as contraction recovered from the massive 23.9 per cent in the first quarter to 7.5% in the quarter ending September. Watch Rajeev Dubey, Editor, Business Today break it down and tell what's working and what's not. Watch More: Will Atmanirbhar 3.0 stimulus package help revive the economy?


Rajeev Dubey
New Delhi, November 25, 2020
In stark contrast to the mayhem around the world, India's top three candidates - Serum-Oxford, Bharat Biotech and Zydus Cadila continued their scientific pursuits unobtrusively (the fourth, DRL-Gamaleya, just started India trials). At least 16 more vaccines are under development at home


Rajeev Dubey
New Delhi, November 18, 2020
Reserve Bank of India (RBI) on Tuesday announced that Lakshmi Vilas Bank had been placed under moratorium by the Union Ministry of Finance till December 16 this year. The decision by the central government, at the request of the RBI, was prompted by a \"steady decline\" in Lakshmi Vilas Bank's financial position over the last three years. Watch as Rajeev Dubey, Editor, Business Today explains the direct impact of the decision on bank customers.Also Read: Lakshmi Vilas Bank under moratorium: What does it mean for depositors?


Rajeev Dubey
New Delhi, November 14, 2020
Ahead of Diwali, Finance Minister Nirmala Sitharaman on Thursday announced a host of measures to boost the economy. She introduced Atmanirbhar Bharat 3.0 stimulus package for the first time home buyers, farmers, informal sectors and others. The package, which involved subsidies for companies that make fresh hirings, has been in the works for more than three months, focused on helping stressed sectors, middle income groups, MSMEs. But, to what extent the new stimulus can help in economy's revival? Rajeev Dubey, Editor, Business Today explains.Also Read: FinMin invites public suggestions, ideas for Union Budget 2021-22


Rajeev Dubey
New Delhi, November 12, 2020
What is already visible in India Inc.'s health are the effects of 18 quarters of persistent slowdown. After all, while Coronavirus was unanticipated, the slowdown preceding it was not


Rajeev Dubey
New Delhi, November 10, 2020
In a major breakthrough in COVID-19 vaccine work, American pharmaceutical giant Pfizer and German firm BioNTech claimed that their vaccine candidate has been found to be 90% effective. The vaccine firms are the first drugmakers to show successful data from a large-scale clinical trial of coronavirus vaccine. The shots made by Pfizer and its German partner BioNTech are among 10 possible vaccine candidates in late-stage testing around the world. How Pfizer vaccine will act as a game changer for the US market, Rajeev Dubey, Editor, Business Today explains.Also Read: Sensex crosses 43,000 for first time, Nifty nears 12,600 on COVID-19 vaccine hopes


Rajeev Dubey
New Delhi, November 3, 2020
India's eagerly awaited economic recovery appears to be finally playing out amidst a slew of contradictions. With the economy showing signs of recovery and the automobile sector witnessing a big jump in sales, the experts believe that the hike could be a result of the festive season. So, is the Indian economy really bouncing back or will there be a requirement for more stimulus? Rajeev Dubey, Editor, Business Today explains.Also Read: Tweedledum and Tweedledee of economic recovery; Where it's working - where it's not


Rajeev Dubey
New Delhi, October 29, 2020
Even more than Coronavirus, the biggest and the most emphatic challenge in the luxury market is how to cater to the needs of Millennials and the Gen-Z when brands and their offerings were originally designed for the baby-boomers


PAGES 2 OF 8  12345